Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q2 2015 · 10-Q
Revenue$78.06K$78.06K−21.1% vs Q2 2014 Net Income-$1.77M-$1.77MN/M vs Q2 2014 EPS Diluted-$0.04-$0.04N/M vs Q2 2014 Gross Profit$58,442−28.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flowderived-$502,395N/M Free Cash Flowderived-$502,395— Margins · derivedGross margin74.9%−8.0 pt vs Q2 2014
Operating margin-1276.0%−628.2 pt vs Q2 2014
Net margin-2261.9%−928.3 pt vs Q2 2014
ended Jun 30, 2015 · filed Aug 18, 2015 · 49 d after period end